Form 4 for CLRB Cellectar Biosciences, Inc.
Accepted 2023-12-12 00:00:00 ET · period of report 2023-06-23 · accession 0001104659-23-125488 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-12 | 2023-12-08 | CLRB | Lea Darrell Shane | Chief Commercial Off | A - Grant | $0.00 | +39.6K | 39.6K | New | $0 |
| D | 2023-12-12 | 2023-06-23 | CLRB | Lea Darrell Shane | Chief Commercial Off | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-08 | A | A | 39,599 | $0.00 | 39,599 | D | — | — | |
| 2 | Derivative | Stock option (right to buy) | 2023-06-23 | A | A | 100,000 | $0.00 | 100,000 | D | $1.68 · — to 2033-01-17 | 100,000 Common Stock | (F1) This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day. (F2) This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023. |